4-(((2-Aminoethyl)thio)methyl)-5-methylimidazole
38585-67-0Cc1[nH]cnc1CSCCNJEOZNMMOIBLWLV-UHFFFAOYSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden2-[[(4-Methyl-1H-imidazol-5-yl)methyl]thio]ethanamine is an intermediate in the synthesis of N-Cyano-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-carbamimidic Acid Methyl Ester (C988063), an impurity of Cimetidine (C441650). Cimetidine acts as a competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output (1).
38585-67-0DTXSID00191907CHEMBL1625246